Samantha Lynn Recalls Reumofan Plus Tablets for Undeclared Ingredients
Samantha Lynn, Inc. is recalling Reumofan Plus Tablets because they contain undeclared drug ingredients, making them unapproved drugs.
- Product
- Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)
- Category
- Drug
- Distribution
- Distributed nationwide